ghk-cu injectable fda approval Buy (50mg) GHK-Cu Injectable - Team Wellcore
Description
High Tolerability: In human trials involving over 900 subjects, no anti-peptide antibodies or significant adverse events were reported
Why it was included in the FDA ban The agency cited a lack of human trials and the risk for immune reactions and peptide impurities with injectable Thymosin Beta 4
The data presented in Table 7 indicate that increased stability can be imparted to Nle'-AnglV-derived compounds by both N- and C-terminal modification
While these effects are typically milder than exogenous growth hormone, they still represent systemic hormonal changes
